Management of Mucinous Cystic Neoplasms of the Liver.
Biliary
Cystadenocarcinoma
Cystadenoma
Management
Journal
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract
ISSN: 1873-4626
Titre abrégé: J Gastrointest Surg
Pays: United States
ID NLM: 9706084
Informations de publication
Date de publication:
09 2023
09 2023
Historique:
received:
23
03
2023
accepted:
09
05
2023
medline:
21
9
2023
pubmed:
24
5
2023
entrez:
23
5
2023
Statut:
ppublish
Résumé
Mucinous cystic neoplasms of the liver (MCN-L) including biliary cystadenomas (BCA) and biliary cystadenocarcinomas (BCAC) are rare cystic lesions that comprise less than 5% of all liver cysts and affect only a small subset of individuals. We herein review the current evidence regarding the clinical presentation, imaging characteristics, tumor markers, pathological findings, clinical management, and prognosis of MCN-L. A comprehensive review of the literature was performed using MEDLINE/Pubmed and Web of Science databases. In PubMed, the terms "biliary cystadenoma," "biliary cystadenocarcinoma," and "non parasitic hepatic cysts" were queried to identify the most recent data on MCN-L. US imaging, CT, and MRI, as well as consideration of clinicopathological features, are required to appropriately characterize and diagnose hepatic cystic tumors. BCA are premalignant lesions and cannot be reliably differentiated from BCAC based on imaging alone. As such, both types of lesions should be treated with margin-negative surgical resection. Following surgical resection, recurrence is fairly low among patients with BCA and BCAC. Despite having worse long-term outcomes than BCA, the prognosis following surgical resection of BCAC still remains more favorable than other primary malignant liver tumors. MCN-L are rare cystic liver tumors that include BCA and BCAC, which can be difficult to differentiate based on imaging alone. Surgical resection remains the mainstay of management for MCN-L with recurrence being generally uncommon. Future multi-institutional studies are still required to better understand the biology behind BCA and BCAC to improve the care of patients with MCN-L.
Sections du résumé
BACKGROUND
Mucinous cystic neoplasms of the liver (MCN-L) including biliary cystadenomas (BCA) and biliary cystadenocarcinomas (BCAC) are rare cystic lesions that comprise less than 5% of all liver cysts and affect only a small subset of individuals. We herein review the current evidence regarding the clinical presentation, imaging characteristics, tumor markers, pathological findings, clinical management, and prognosis of MCN-L.
METHODS
A comprehensive review of the literature was performed using MEDLINE/Pubmed and Web of Science databases. In PubMed, the terms "biliary cystadenoma," "biliary cystadenocarcinoma," and "non parasitic hepatic cysts" were queried to identify the most recent data on MCN-L.
RESULTS
US imaging, CT, and MRI, as well as consideration of clinicopathological features, are required to appropriately characterize and diagnose hepatic cystic tumors. BCA are premalignant lesions and cannot be reliably differentiated from BCAC based on imaging alone. As such, both types of lesions should be treated with margin-negative surgical resection. Following surgical resection, recurrence is fairly low among patients with BCA and BCAC. Despite having worse long-term outcomes than BCA, the prognosis following surgical resection of BCAC still remains more favorable than other primary malignant liver tumors.
CONCLUSION
MCN-L are rare cystic liver tumors that include BCA and BCAC, which can be difficult to differentiate based on imaging alone. Surgical resection remains the mainstay of management for MCN-L with recurrence being generally uncommon. Future multi-institutional studies are still required to better understand the biology behind BCA and BCAC to improve the care of patients with MCN-L.
Identifiants
pubmed: 37221388
doi: 10.1007/s11605-023-05709-6
pii: 10.1007/s11605-023-05709-6
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1963-1970Informations de copyright
© 2023. The Society for Surgery of the Alimentary Tract.
Références
Walt AJ. Cysts and benign tumors of the liver. Surg Clin North Am 1977;57:449–64 https://doi.org/10.1016/s0039-6109(16)41194-1
doi: 10.1016/s0039-6109(16)41194-1
pubmed: 322342
Vogt DP, Henderson JM, Chmielewski E. Cystadenoma and cystadenocarcinoma of the liver: a single center experience. J Am Coll Surg 2005;200:727–33 https://doi.org/10.1016/j.jamcollsurg.2005.01.005
doi: 10.1016/j.jamcollsurg.2005.01.005
pubmed: 15848365
Kim HH, Hur YH, Koh YS, Cho CK, Kim JW. Intrahepatic biliary cystadenoma: Is there really an almost exclusively female predominance? World J. Gastroenterol.2011;17:3073–4 https://doi.org/10.3748/wjg.v17.i25.3073
doi: 10.3748/wjg.v17.i25.3073
pubmed: 21799657
pmcid: 3132262
Devaney K, Goodman ZD, Ishak KG. Hepatobiliary cystadenoma and cystadenocarcinoma. A light microscopic and immunohistochemical study of 70 patients. Am J Surg Pathol 1994;18:1078–91
doi: 10.1097/00000478-199411000-00002
pubmed: 7943529
Läuffer JM, Baer HU, Maurer CA, Stoupis C, Zimmerman A, Büchler MW. Biliary cystadenocarcinoma of the liver: the need for complete resection. Eur J Cancer 1998;34:1845–51 https://doi.org/10.1016/s0959-8049(98)00166-x
doi: 10.1016/s0959-8049(98)00166-x
pubmed: 10023304
Short WF, Nedwich A, Levy HA, Howard JM. Biliary cystadenoma. Report of a case and review of the literature. Arch Surg 1971;102:78–80 https://doi.org/10.1001/archsurg.1971.01350010080021
doi: 10.1001/archsurg.1971.01350010080021
pubmed: 5538773
HENSON SWJ, GRAY HK, DOCKERTY MB. Benign tumors of the liver. VI. Multilocular cystadenomas. Surg Gynecol Obstet 1957;104:551–4
pubmed: 13433250
Edmondson HA. Atlas of Tumor Pathology: tumors of the liver and intrahepatic bile ducts. 1958.
Soochan D, Keough V, Wanless I, Molinari M. Intra and extra-hepatic cystadenoma of the biliary duct. Review of literature and radiological and pathological characteristics of a very rare case. BMJ Case Rep 2012;2012. https://doi.org/10.1136/bcr.01.2012.5497
Wheeler DA, Edmondson HA. Cystadenoma with mesenchymal stroma (CMS) in the liver and bile ducts. A clinicopathologic study of 17 cases, 4 with malignant change. Cancer 1985;56:1434–45 https://doi.org/10.1002/1097-0142(19850915)56:6/1434::aid-cncr2820560635/3.0.co;2-f
doi: 10.1002/1097-0142(19850915)56:6<1434::aid-cncr2820560635>3.0.co;2-f
pubmed: 4027877
Akwari OE, Tucker A, Seigler HF, Itani KM. Hepatobiliary cystadenoma with mesenchymal stroma. Ann Surg 1990;211:18–27 https://doi.org/10.1097/00000658-199001000-00004
doi: 10.1097/00000658-199001000-00004
pubmed: 2403772
pmcid: 1357888
Soares KC, Arnaoutakis DJ, Kamel I, Anders R, Adams RB, Bauer TW, Pawlik TM. Cystic neoplasms of the liver: biliary cystadenoma and cystadenocarcinoma. J Am Coll Surg 2014;218:119–28 https://doi.org/10.1016/j.jamcollsurg.2013.08.014
doi: 10.1016/j.jamcollsurg.2013.08.014
pubmed: 24045144
Thomas KT, Welch D, Trueblood A, Sulur P, Wise P, Gorden DL, Chari RS, Wright JKJ, Washington K, Pinson CW. Effective treatment of biliary cystadenoma. Ann Surg 2005;241:765–9 https://doi.org/10.1097/01.sla.0000161982.57360.1b
doi: 10.1097/01.sla.0000161982.57360.1b
Hansman MF, Ryan JAJ, Holmes JH 4th, Hogan S, Lee FT, Kramer D, Biehl T. Management and long-term follow-up of hepatic cysts. Am J Surg 2001;181:404–10 https://doi.org/10.1016/s0002-9610(01)00611-0
doi: 10.1016/s0002-9610(01)00611-0
pubmed: 11448430
Ritchie DJ, Okamoto K, White SL. Intraductal papillary mucinous neoplasm of the biliary tract: A precursor lesion to cholangiocarcinoma. Radiol. case reports2019;14:495–500 [PMID: 30815047 https://doi.org/10.1016/j.radcr.2019.01.023 ]
doi: 10.1016/j.radcr.2019.01.023
Zen Y, Fujii T, Itatsu K, Nakamura K, Konishi F, Masuda S, Mitsui T, Asada Y, Miura S, Miyayama S, Uehara T, Katsuyama T, Ohta T, Minato H, Nakanuma Y. Biliary cystic tumors with bile duct communication: a cystic variant of intraductal papillary neoplasm of the bile duct. Mod Pathol an Off J United States Can Acad Pathol Inc 2006;19:1243–54. https://doi.org/10.1038/modpathol.3800643
Lantinga MA, Gevers TJG, Drenth JPH. Evaluation of hepatic cystic lesions. World J Gastroenterol 2013;19:3543–54 https://doi.org/10.3748/wjg.v19.i23.3543
doi: 10.3748/wjg.v19.i23.3543
pubmed: 23801855
pmcid: 3691048
Boyum JH, Sheedy SP, Graham RP, Olson JT, Babcock AT, Bolan CW, Menias CO, Venkatesh SK. Hepatic Mucinous Cystic Neoplasm Versus Simple Biliary Cyst: Assessment of Distinguishing Imaging Features Using CT and MRI. AJR Am J Roentgenol 2021;216:403–11 https://doi.org/10.2214/AJR.20.22768
doi: 10.2214/AJR.20.22768
pubmed: 33356432
Doussot A, Gluskin J, Groot-Koerkamp B, Allen PJ, De Matteo RP, Shia J, Kingham TP, Jarnagin WR, Gerst SR, D’Angelica MI. The accuracy of pre-operative imaging in the management of hepatic cysts. HPB Off J Int Hepato Pancreato Biliary Assoc 2015;17:889–95 https://doi.org/10.1111/hpb.12443
doi: 10.1111/hpb.12443
Quigley B, Reid MD, Pehlivanoglu B, Squires MH 3rd, Maithel S, Xue Y, Hyejeong C, Akkas G, Muraki T, Kooby DA, Sarmiento JM, Cardona K, Sekhar A, Krasinskas A, Adsay V. Hepatobiliary Mucinous Cystic Neoplasms With Ovarian Type Stroma (So-Called ‘Hepatobiliary Cystadenoma/Cystadenocarcinoma’): Clinicopathologic Analysis of 36 Cases Illustrates Rarity of Carcinomatous Change. Am J Surg Pathol 2018;42:95–102 https://doi.org/10.1097/PAS.0000000000000963
doi: 10.1097/PAS.0000000000000963
pubmed: 29016404
Klompenhouwer AJ, ten Cate DWG, Willemssen FEJA, Bramer WM, Doukas M, de Man RA, Ijzermans JNM. The impact of imaging on the surgical management of biliary cystadenomas and cystadenocarcinomas; a systematic review. HPB [Internet] 2019;21:1257–67 https://doi.org/10.1016/j.hpb.2019.04.004 ] Available from: https://www.sciencedirect.com/science/article/pii/S1365182X19305209
doi: 10.1016/j.hpb.2019.04.004
pubmed: 31085104
Buetow PC, Buck JL, Pantongrag-Brown L, Ros PR, Devaney K, Goodman ZD, Cruess DF. Biliary cystadenoma and cystadenocarcinoma: clinical-imaging-pathologic correlations with emphasis on the importance of ovarian stroma. Radiology 1995;196:805–10 https://doi.org/10.1148/radiology.196.3.7644647
doi: 10.1148/radiology.196.3.7644647
pubmed: 7644647
Xu H-X, Lu M-D, Liu L-N, Zhang Y-F, Guo L-H, Liu C, Wang S. Imaging features of intrahepatic biliary cystadenoma and cystadenocarcinoma on B-mode and contrast-enhanced ultrasound. Ultraschall Med 2012;33:E241–9 https://doi.org/10.1055/s-0031-1299276
doi: 10.1055/s-0031-1299276
pubmed: 23154870
Seo JK, Kim SH, Lee SH, Park JK, Woo SM, Jeong JB, Hwang J-H, Ryu JK, Kim J-W, Jeong S-H, Kim Y-T, Yoon YB, Lee KU, Kim SH, Kim MA. Appropriate diagnosis of biliary cystic tumors: comparison with atypical hepatic simple cysts. Eur J Gastroenterol Hepatol 2010;22:989–96 https://doi.org/10.1097/MEG.0b013e328337c971
doi: 10.1097/MEG.0b013e328337c971
pubmed: 20300006
Shyu S, Singhi AD. Cystic biliary tumors of the liver: diagnostic criteria and common pitfalls. Hum Pathol 2021;112:70–83 https://doi.org/10.1016/j.humpath.2020.12.010
doi: 10.1016/j.humpath.2020.12.010
pubmed: 33383041
Korobkin M, Stephens DH, Lee JK, Stanley RJ, Fishman EK, Francis IR, Alpern MB, Rynties M. Biliary cystadenoma and cystadenocarcinoma: CT and sonographic findings. AJR Am J Roentgenol 1989;153:507–11 https://doi.org/10.2214/ajr.153.3.507
doi: 10.2214/ajr.153.3.507
pubmed: 2669463
Lee MH, Katabathina VS, Lubner MG, Shah HU, Prasad SR, Matkowskyj KA, Pickhardt PJ. Mucin-producing Cystic Hepatobiliary Neoplasms: Updated Nomenclature and Clinical, Pathologic, and Imaging Features. Radiogr a Rev Publ Radiol Soc North Am Inc 2021;41:1592–610. https://doi.org/10.1148/rg.2021210011
Kim HJ, Yu ES, Byun JH, Hong S-M, Kim KW, Lee JS, Kim SY. CT differentiation of mucin-producing cystic neoplasms of the liver from solitary bile duct cysts. AJR Am J Roentgenol 2014;202:83–91 https://doi.org/10.2214/AJR.12.9170
doi: 10.2214/AJR.12.9170
pubmed: 24370132
Arnaoutakis DJ, Kim Y, Pulitano C, Zaydfudim V, Squires MH, Kooby D, Groeschl R, Alexandrescu S, Bauer TW, Bloomston M, Soares K, Marques H, Gamblin TC, Popescu I, Adams R, Nagorney D, Barroso E, Maithel SK, Crawford M, Sandroussi C, Marsh W, Pawlik TM. Management of biliary cystic tumors: a multi-institutional analysis of a rare liver tumor. Ann Surg 2015;261:361–7 https://doi.org/10.1097/SLA.0000000000000543
doi: 10.1097/SLA.0000000000000543
pubmed: 24509187
Zen Y, Pedica F, Patcha VR, Capelli P, Zamboni G, Casaril A, Quaglia A, Nakanuma Y, Heaton N, Portmann B. Mucinous cystic neoplasms of the liver: a clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct. Mod Pathol an Off J United States Can Acad Pathol Inc 2011;24:1079–89. https://doi.org/10.1038/modpathol.2011.71
Zen Y, Jang K-T, Ahn S, Kim DH, Choi DW, Choi SH, Heo JS, Yeh MM. Intraductal papillary neoplasms and mucinous cystic neoplasms of the hepatobiliary system: demographic differences between Asian and Western populations, and comparison with pancreatic counterparts. Histopathology 2014;65:164–73 https://doi.org/10.1111/his.12378
doi: 10.1111/his.12378
pubmed: 24456415
Kubota K, Nakanuma Y, Kondo F, Hachiya H, Miyazaki M, Nagino M, Yamamoto M, Isayama H, Tabata M, Kinoshita H, Kamisawa T, Inui K. Clinicopathological features and prognosis of mucin-producing bile duct tumor and mucinous cystic tumor of the liver: a multi-institutional study by the Japan Biliary Association. J Hepatobiliary Pancreat Sci 2014;21:176–85 https://doi.org/10.1002/jhbp.23
doi: 10.1002/jhbp.23
pubmed: 23908126
Kim JY, Kim SH, Eun HW, Lee MW, Lee JY, Han JK, Choi BI. Differentiation between biliary cystic neoplasms and simple cysts of the liver: accuracy of CT. AJR Am J Roentgenol 2010;195:1142–8 https://doi.org/10.2214/AJR.09.4026
doi: 10.2214/AJR.09.4026
pubmed: 20966320
Matsumoto S, Miyake H, Mori H. Case report: biliary cystadenoma with mucin-secretion mimicking a simple hepatic cyst. Clin Radiol 1997;52:316–8 https://doi.org/10.1016/s0009-9260(97)80065-7
doi: 10.1016/s0009-9260(97)80065-7
pubmed: 9112956
Ishak KG, Willis GW, Cummins SD, Bullock AA. Biliary cystadenoma and cystadenocarcinoma: report of 14 cases and review of the literature. Cancer 1977;39:322–38 https://doi.org/10.1002/1097-0142(197701)39:1/322::aid-cncr2820390149/3.0.co;2-p
doi: 10.1002/1097-0142(197701)39:1<322::aid-cncr2820390149>3.0.co;2-p
pubmed: 318915
Williams DM, Vitellas KM, Sheafor D. Biliary cystadenocarcinoma: seven year follow-up and the role of MRI and MRCP. Magn Reson Imaging 2001;19:1203–8 https://doi.org/10.1016/s0730-725x(01)00453-2
doi: 10.1016/s0730-725x(01)00453-2
pubmed: 11755730
Lewin M, Mourra N, Honigman I, Fléjou J-F, Parc R, Arrivé L, Tubiana J-M. Assessment of MRI and MRCP in diagnosis of biliary cystadenoma and cystadenocarcinoma. Eur Radiol 2006;16:407–13 https://doi.org/10.1007/s00330-005-2822-x
doi: 10.1007/s00330-005-2822-x
pubmed: 15983777
Pinto MM, Kaye AD. Fine needle aspiration of cystic liver lesions. Cytologic examination and carcinoembryonic antigen assay of cyst contents. Acta Cytol 1989;33:852–6
pubmed: 2686325
Tomioka T, Tsuchiya R, Harada N, Tsunoda T, Matsuo T. Cystadenoma and cystadenocarcinoma of the liver: localization of carcinoembryonic antigen. Jpn J Surg 1986;16:62–7 https://doi.org/10.1007/BF02471072
doi: 10.1007/BF02471072
pubmed: 3515006
D’Errico A, Deleonardi G, Fiorentino M, Scoazec JY, Grigioni WF. Diagnostic implications of albumin messenger RNA detection and cytokeratin pattern in benign hepatic lesions and biliary cystadenocarcinoma. Diagnostic Mol Pathol Am J Surg Pathol part B 1998;7:289–94 https://doi.org/10.1097/00019606-199812000-00001
doi: 10.1097/00019606-199812000-00001
Chen YW, Li CH, Liu Z, Dong JH, Zhang WZ, Jiang K. Surgical management of biliary cystadenoma and cystadenocarcinoma of the liver. Genet Mol Res 2014;13:6383–90 https://doi.org/10.4238/2014.August.25.1
doi: 10.4238/2014.August.25.1
pubmed: 25158256
Erdogan D, Kloek J, Lamers WH, Offerhaus GJA, Busch ORC, Gouma DJ, van Gulik TM. Mucinous cystadenomas in liver: management and origin. Dig Surg 2010;27:19–23 https://doi.org/10.1159/000268110
doi: 10.1159/000268110
pubmed: 20357447
Sutton CD, White SA, Berry DP, Dennison AR. Intrahepatic biliary cystadenoma causing luminal common bile duct obstruction. Dig Surg 2000;17:297–9. https://doi.org/10.1159/000018857
doi: 10.1159/000018857
pubmed: 10867471
Teoh AYB, Ng SSM, Lee KF, Lai PBS. Biliary cystadenoma and other complicated cystic lesions of the liver: diagnostic and therapeutic challenges. World J Surg 2006;30:1560–6 https://doi.org/10.1007/s00268-005-0461-7
doi: 10.1007/s00268-005-0461-7
pubmed: 16865321
Koffron A, Rao S, Ferrario M, Abecassis M. Intrahepatic biliary cystadenoma: role of cyst fluid analysis and surgical management in the laparoscopic era. Surgery 2004;136:926–36 [PMID: 15467680 https://doi.org/10.1016/j.surg.2004.06.031 ]
doi: 10.1016/j.surg.2004.06.031
pubmed: 15467680
Manouras A, Lagoudianakis E, Alevizos L, Markogiannakis H, Kafiri G, Bramis C, Filis K, Toutouzas K. Laparoscopic fenestration of multiple giant biliary mucinous cystadenomas of the liver. World J Gastroenterol 2008;14:4257–9. https://doi.org/10.3748/wjg.14.4257
doi: 10.3748/wjg.14.4257
pubmed: 18636678
pmcid: 2725394
Marsh JL, Dahms B, Longmire WPJ. Cystadenoma and cystadenocarcinoma of the biliary system. Arch Surg 1974;109:41–3. https://doi.org/10.1001/archsurg.1974.01360010027005
doi: 10.1001/archsurg.1974.01360010027005
pubmed: 4834134
Ardito F, Tayar C, Laurent A, Karoui M, Loriau J, Cherqui D. Laparoscopic liver resection for benign disease. Arch Surg 2007;142:1188–93; discussion 1193. https://doi.org/10.1001/archsurg.142.12.1188
doi: 10.1001/archsurg.142.12.1188
pubmed: 18086986
Abu Hilal M, Di Fabio F, Teng MJ, Godfrey DA, Primrose JN, Pearce NW. Surgical management of benign and indeterminate hepatic lesions in the era of laparoscopic liver surgery. Dig Surg 2011;28:232–6. https://doi.org/10.1159/000321891
doi: 10.1159/000321891
pubmed: 21546776
Hai S, Hirohashi K, Uenishi T, Yamamoto T, Shuto T, Tanaka H, Kubo S, Tanaka S, Kinoshita H. Surgical management of cystic hepatic neoplasms. J Gastroenterol 2003;38:759–64. https://doi.org/10.1007/s00535-003-1142-7
doi: 10.1007/s00535-003-1142-7
pubmed: 14505130
Romagnoli R, Patrono D, Paraluppi G, David E, Tandoi F, Strignano P, Lupo F, Salizzoni M. Liver transplantation for symptomatic centrohepatic biliary cystadenoma. Clin Res Hepatol Gastroenterol 2011;35:408–13. https://doi.org/10.1016/j.clinre.2011.03.014
doi: 10.1016/j.clinre.2011.03.014
pubmed: 21549659
Sang X, Sun Y, Mao Y, Yang Z, Lu X, Yang H, Xu H, Zhong S, Huang J. Hepatobiliary cystadenomas and cystadenocarcinomas: a report of 33 cases. Liver Int Off J Int Assoc Study Liver 2011;31:1337–44. https://doi.org/10.1111/j.1478-3231.2011.02560.x
doi: 10.1111/j.1478-3231.2011.02560.x
Nakajima T, Sugano I, Matsuzaki O, Nagao K, Kondo Y, Miyazaki M, Wada K. Biliary cystadenocarcinoma of the liver. A clinicopathologic and histochemical evaluation of nine cases. Cancer 1992;69:2426–32 https://doi.org/10.1002/1097-0142(19920515)69:10/2426::aid-cncr2820691007/3.0.co;2-3
doi: 10.1002/1097-0142(19920515)69:10<2426::aid-cncr2820691007>3.0.co;2-3
pubmed: 1314687
Hanazaki K, Yoshizawa K, Mori H. Hepatic arterial infusion chemotherapy of cisplatin for biliary cystadenocarcinoma. Hepatogastroenterology 1999;46:462–4
pubmed: 10228843
Iyama S, Takahashi Y, Shintani N, Fujikawa K, Ohkubo S, Sato Y, Sato T, Sato Y, Ohnuma K, Niitsu Y. [A case of recurrent biliary cystadenocarcinoma successfully treated with 5FU/CDDP systemic chemotherapy]. Nihon Shokakibyo Gakkai Zasshi 2006;103:1163–8
pubmed: 17023760